Multiple myeloma: changes in serum C-terminal telopeptide of collagen type I and bone-specific alkaline phosphatase can be used in daily practice to detect imminent osteolysis*

Objective: Monitoring of bone disease in multiple myeloma is becoming increasingly important because bone-protecting treatment with bisphosphonate is becoming restricted after the awareness of osteonecrosis of the jaw. Despite the potential of biochemical markers of bone remodeling to monitor dynami...

Descripción completa

Detalles Bibliográficos
Autores principales: Lund, Thomas, Abildgaard, Niels, Andersen, Thomas L, Delaisse, Jean-Marie, Plesner, Torben
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871171/
https://www.ncbi.nlm.nih.gov/pubmed/20070853
http://dx.doi.org/10.1111/j.1600-0609.2010.01417.x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871171/
https://www.ncbi.nlm.nih.gov/pubmed/20070853
http://dx.doi.org/10.1111/j.1600-0609.2010.01417.x

Ejemplares similares